New drug approvals held steady in 2021

被引：0
|
作者：
Halford, Bethany
机构：
来源：
CHEMICAL & ENGINEERING NEWS | 2022年 / 100卷 / 02期
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
引用
收藏
页码：17 / 17
页数：1
相关论文
共 50 条
  • [1] Approvals in 2021: dangling Accelerated Approvals, drug dosing, new approvals and beyond
    Lemery, Steven
    Pazdur, Richard
    [J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2022, 19 (04) : 217 - 218
  • [2] Approvals in 2021: dangling Accelerated Approvals, drug dosing, new approvals and beyond
    Steven Lemery
    Richard Pazdur
    [J]. Nature Reviews Clinical Oncology, 2022, 19 : 217 - 218
  • [3] New drug approvals for 2021: Synthesis and clinical applications
    Yuan, Shuo
    Wang, Dan-Shu
    Liu, Hui
    Zhang, Sheng-Nan
    Yang, Wei-Guang
    Lv, Meng
    Zhou, Yu-Xue
    Zhang, Sai-Yang
    Song, Jian
    Liu, Hong-Min
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 245
  • [4] FDA new drug approvals in Q1 2021
    Urquhart, Lisa
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2021, 20 (05) : 334 - 334
  • [5] FDA new drug approvals in Q2 2021
    Lisa Urquhart
    [J]. Nature Reviews Drug Discovery, 2021, 20 : 578 - 578
  • [6] Trends and Characteristics of New Drug Approvals in China, 2011–2021
    Ling Su
    Sen Liu
    Guanqiao Li
    Cuicui Xie
    Huan Yang
    Yang Liu
    Chen Yin
    Xiaoyuan Chen
    [J]. Therapeutic Innovation & Regulatory Science, 2023, 57 : 343 - 351
  • [7] FDA new drug approvals in Q3 2021
    Urquhart, Lisa
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2021, 20 (11) : 807 - 807
  • [8] FDA new drug approvals in Q3 2021
    Lisa Urquhart
    [J]. Nature Reviews Drug Discovery, 2021, 20 : 807 - 807
  • [9] FDA new drug approvals in Q1 2021
    Lisa Urquhart
    [J]. Nature Reviews Drug Discovery, 2021, 20 : 334 - 334
  • [10] Cancer drug approvals and setbacks in 2021
    Mullard, Asher
    [J]. NATURE CANCER, 2021, 2 (12) : 1246 - 1247
12345